Guidelines for the diagnosis and management of neuropathic pain: Consensus of a group of latin american experts

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 23, Issue 3, 2009, Pages 261-281

  Bistre, Sara ^b   Acevedo, Juan Carlos ^a   Amaya, Abraham ^b   De León Casasola, Oscar ^c   Chinchilla, Nelson ^d   De Giorgis, Marcelo ^e   Flórez, Sandra ^f   Genis, Miguel Ángel ^g   Gómez Barrios, Juan Vicente ^h   Hernández, John Jairo ⁱ   Ibarra, Eduardo ^j   Moreno, Carlos ⁱ   Orrillo, Enrique ^k   Pasternak, Danilo ^l   Romero, Sabina ^m   Vallejo, Mariana ⁿ   Velasco, Maritza ^o   Villalobos, Alberto ^p  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b Sociedad Salvadoreña de Neurocirugía ^*

^c UNIVERSITY AT BUFFALO   (United States)

^d Hospital del Valle   (Honduras)

^e Unidad de Dolor   (Chile)

^f UNIVERSIDAD DE LA SABANA   (Colombia)

^g Hospital General de Tlalnepantla Valle Ceylan   (Mexico)

^h UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

ⁱ UNIVERSIDAD DEL ROSARIO   (Colombia)

^j Clínica C W Long de Manejo Del Dolor   (Puerto Rico)

^k Lima   (Peru)

^l HOSPITAL METROPOLITANO   (Ecuador)

^m Hospital Miguel Perez Carreno   (Venezuela)

ⁿ SOLCA   (Ecuador)

^o HOSPITAL MILITAR DE SANTIAGO   (Chile)

^p UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

more..

Author keywords

Consensus; Guidelines; Latin America; Neuropathic pain

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; BUPRENORPHINE; CANNABINOID; CARBAMAZEPINE; CYTIDINE PHOSPHATE; DESIPRAMINE; DULOXETINE; FENTANYL; FLUOXETINE; GABAPENTIN; IMIPRAMINE; KETAMINE; LAMOTRIGINE; LIDOCAINE; METHADONE; MORPHINE; NABILONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; OXYCODONE; PREGABALIN; THIOCTIC ACID; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; URIDINE PHOSPHATE; VENLAFAXINE;

ACUPUNCTURE; ADULT; ARTICLE; CLINICAL PROTOCOL; CONSENSUS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; HUMAN; INVASIVE PROCEDURE; LOW DRUG DOSE; MEDICAL EXPERT; MEDICAL PRACTICE; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PHYTOTHERAPY; PRACTICE GUIDELINE; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REHABILITATION CARE; SIDE EFFECT; SOUTH AND CENTRAL AMERICA; SYMPTOM; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ANALGESICS; HUMANS; LATIN AMERICA; NEURALGIA; PAIN MEASUREMENT; PRACTICE GUIDELINES AS TOPIC;

EID: 70849132841     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1080/15360280903098572     Document Type: Article

References (21)

1. Barbano RL, Herrmann NP, Hart-Gouleau S, Pennella-Vaughan J, Lodewick PA, Dworkin RH. Effectiveness, tolerability and QoL of the lidocaine patch in diabetic polyneuropathy. ArchNeurol. 2004; 61: 914-918.
2. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: reviewof clinical and experimental evidence. Pain. 1993; 52:259-285.
3. Cruccu G, Anand P, Attal N, et al. Guidelines on neuropathic pain assessment. Eur J Neurol. 2004; 11: 153-162.
4. Davis M. What is new in neuropathic pain? Support Cancer Care. 2007; 15: 221-224.
5. De Leon-Casasola O. Multimodal approaches to the management of neuropathic pain: the role of topical analgesia. J Pain Symptom Manage. 2007; 33: 356-364.
6. Delorme C, Navez M, Legout V, Deleens R, Moyse D. Lidocaine patch: 5 years of clinical experience. PW 349. Abstract.World Congress on Pain. Glasgow. August 17-22, 2008.
7. Fĺorez S, Pedraza J. Cifuentes LF. Clinical experience with the lidocaine patch in a Latin American population. Abstract. PW354.World Congress on Pain. Glasgow. August 17-22, 2008.
8. Hans G. Buprenorphine: a review of its role in neuropathic pain. J Opioid Manag. 2007; 3:195-206.
9. Herńandez JJ y Moreno C. Dolor neuroṕatico, la gran inćognita. En: Dolor neuroṕatico: fisiopatología, diagńostico y manejo. Editores: Herńandez JJ y Moreno C. Editorial Colombia: Universidad del Rosario;2006:20-31.
10. Johnson RW, Dworkin RH. Treatment of herpes zoster and postherpetic neuralgia. BMJ. 2003; 326:748-750.
11. Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain. 1996; 64: 293-302.
12. Lai J, Porreca F, Hunter JC, Gold MS. Voltagegated odium channels and hyperalgesia.Annu Rev Pharmacol Toxicol. 2004; 44:371-397.
13. Lockhart E. Topical combination of amitriptyline and ketamine for post herpetic neuralgia [abstract]. Poster presentation, American Pain Society. Annual Meeting,Vancouver,BCCanada, 2004. http://www. ampainsoc. org/db2/abstract/view 2185#893.
14. McDermott AM, Tölle TR, Rowbotham DJ, Schaefer CP, Dukes EM: The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain. 2006; 10: 127-135.
15. MendisV, Farrar S.Assessing efficacy of the lidocaine 5% plaster for localised chronic neuropathic pain: results from a UK hospital based retrospective audit. PW 349. Abstract. World Congress on Pain. Glasgow. August 17-22, 2008
16. Mercadante S, Arcuri E, Tirelli W, et al. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori. 2002; 88: 239-242.
17. Merskey H, Bogduk N. Classification of Chronic Pain. 2nd ed. Seattle: IASP Press; 1994:209-214.
18. Descripcíon de la disponibilidad de opioides en Aḿerica Latina. Rev Iberoamericana del Dolor. 2008;1. http://www. revistaiberoamericanadedolor.org/
19. Rehm S, Binder A, Boesl I, R. Baron R. A new topical lidocaine-medicated plaster for post-herpetic neuralgia: results of a multi-national, double-blind, placebo-controlled efficacy and safety trial. Abstract. PW 225. World Congress on Pain. Glasgow. August 17-22, 2008.
20. Schattschneider J, Baron R, Binder A, Wasner G, Steigerwald I. A comparison of quality of life and safety outcomes from a randomized, controlled trial of a topical lidocaine-medicated plaster versus pregabalin for patients with post-herpetic neuralgia and painful diabetic polineuropathy. Abstract. PW 185. World Congress on Pain. Glasgow. August 17-22, 2008.
21. Vadalouca A, Siafaka I, Argyra E, Vrachnou E, and Moka E. Therapeutic management of chronic neuropathic pain an examination of pharmacologic treatment. Ann N Y Acad Sci. 2006; 1088:164-186.